Awaiting FDA information on Pfizer vaccine safety for kids: BPOM

In the future, we hope that the Pfizer vaccine will be released from the USFDA. We are still waiting for its registration. BPOM can not right away permit

Jakarta – The National Company of Drug and Food Control (BPOM) stated it is awaiting the results of research study by the United States Food and Drug Administration (US FDA) on administering the Pfizer vaccine to kids.

” In the future, we hope that the Pfizer vaccine will be launched from the USFDA. We are still waiting on its registration. BPOM can not right away give permission,” Head of BPOM Cent K Lukito said here on Tuesday.

The USFDA has the capability to provide strict standards concerning COVID-19 vaccines, which can be the basis for the BPOM to approve permission to utilize the Pfizer vaccine in Indonesia, she added.

Related news: COVID-19: BPOM approves Sinovac vaccine for kids aged 6-11

Currently, the only vaccine brand name approved for children aged 6 to 11 in Indonesia is Sinovac, she said.

Vaccinations for kids are important due to the fact that aside from the threat of children being virus providers, schools are starting to execute limited in person learning, she included.

COVID-19 vaccinations could encourage parents to permit their children to go to face-to-face knowing, she said.

To enhance immunity versus COVID-19, the Indonesian federal government presented a vaccination program throughout the country on January 13,2021 President Joko Widodo was the very first person to get a COVID-19 vaccine in the nation.

Related news: BPOM extends assistance for 15 researches on COVID-19 natural medicines

In general, the Indonesian federal government is targeting to inoculate 208,265,720 people under the program.

According to the Health Ministry’s information, since November 2, 2021, nearly 121,365,081 citizens have gotten their very first COVID-19 vaccine dosage, while 75,217,214 have been fully vaccinated versus the infection.

BPOM just recently released a permit approving the Sinovac vaccine for kids aged 6 to 11 years based on a security and resistance assessment.

Related news: 2 million kids at threat of stunting throughout pandemic: BKKBN

Associated news: BPOM simplifies permit issuance for processed food distribution

Share this post

Leave a Reply

Your email address will not be published. Required fields are marked *

scroll to top